Novel Mechanisms
to Solve Old Problems
Research to Make Life Better
Memosyne
We are a company dedicated to researching and synthesizing chemical compounds for treatment and therapeutical purposes. Our primary focus is the development of a novel peptide-based mechanism to treat Alzheimer's Disease, which has proved effective and could constitute a solution for the treatment of dementia on a global scale.
About Us
Memosyne is composed by a team of experienced and renowned professionals from various industries. Our research group comprises biochemists, biophysicists, specialists in neuropathology and renowned scientists.
The company's managing partners have extensive experience in the pharmaceutical industry, economics and international and corporate law.
Alzheimer's Disease Project
Based on a novel mechanism of action, based on the team’s new findings, we are developing a group of peptides that have successfully proven to stop the progress of mental deterioration in animal experiments and recover cognitive capacities.
Due to the outstanding progress and results in our research, our primary goal is to find funding sources to develop the project further into pre-clinical and clinical phases.